| In vitro tumor models: Advantages, disadvantages, variables, and selecting the right platform ME Katt, AL Placone, AD Wong, ZS Xu, PC Searson Frontiers in bioengineering and biotechnology 4, 2016 | 874 | 2016 |
| Human brain microvascular endothelial cells derived from the BC1 iPS cell line exhibit a blood-brain barrier phenotype ME Katt, ZS Xu, S Gerecht, PC Searson PloS one 11 (4), e0152105, 2016 | 137 | 2016 |
| Functional brain-specific microvessels from iPSC-derived human brain microvascular endothelial cells: the role of matrix composition on monolayer formation ME Katt, RM Linville, LN Mayo, ZS Xu, PC Searson Fluids and Barriers of the CNS 15, 1-12, 2018 | 101 | 2018 |
| The role of mutations associated with familial neurodegenerative disorders on blood–brain barrier function in an iPSC model ME Katt, LN Mayo, SE Ellis, V Mahairaki, JD Rothstein, L Cheng, ... Fluids and Barriers of the CNS 16, 1-13, 2019 | 64 | 2019 |
| Dissemination from a solid tumor: examining the multiple parallel pathways ME Katt, AD Wong, PC Searson Trends in cancer 4 (1), 20-37, 2018 | 50 | 2018 |
| In vitro models of the blood-brain barrier: building in physiological complexity ME Katt, EV Shusta Current opinion in chemical engineering 30, 42-52, 2020 | 29 | 2020 |
| Human IPSC 3D brain model as a tool to study chemical-induced dopaminergic neuronal toxicity D Pamies, D Wiersma, ME Katt, L Zhao, J Burtscher, G Harris, L Smirnova, ... Neurobiology of disease 169, 105719, 2022 | 17 | 2022 |
| Chemotherapeutic drug delivery and quantitative analysis of proliferation, apoptosis, and migration in a tissue-engineered three-dimensional microvessel model of the tumor … AD Wong, LM Russell, ME Katt, PC Searson ACS Biomaterials Science & Engineering 5 (2), 633-643, 2018 | 17 | 2018 |
| Integrative analysis of the human brain mural cell transcriptome BD Gastfriend, KL Foreman, ME Katt, SP Palecek, EV Shusta Journal of Cerebral Blood Flow & Metabolism 41 (11), 3052-3068, 2021 | 16 | 2021 |
| Identification of lamprey variable lymphocyte receptors that target the brain vasculature JM Lajoie, ME Katt, EA Waters, BR Herrin, EV Shusta Scientific Reports 12 (1), 6044, 2022 | 8 | 2022 |
| The 46.1 antibody mediates neurotensin uptake into the CNS and the effects depend on the route of intravenous administration JV Georgieva, M Katt, Z Ye, BJ Umlauf, CJ Wenthur, EV Shusta Pharmaceutics 14 (8), 1706, 2022 | 4 | 2022 |
Peter SearsonReynolds Professor of Engineering, Johns Hopkins University在 jhu.edu 的电子邮件经过验证
